Study of Sacituzumab Govitecan in Participants With Metastatic Solid Tumors

Running, not enrolling · Phase 2

Conditions studied: Metastatic Solid Tumor

In brief

The goal of this clinical study is to learn more about the study drug, sacituzumab govitecan-hziy, in participants with metastatic (cancer that has spread) solid tumors.

Key facts

Study ID
NCT03964727
Run by
Gilead Sciences
People needed
227
Starts
2019-10-15
Expected to finish
2026-12-01
Last updated by the study team
2026-04-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.